Biotech developing a second-generation Covid-19 vaccine.
| Date | Round | Amount |
|---|---|---|
| Aug 2021 | Series A Basel biotech RocketVax raised a CHF 7.2M Series A to fund pre-clinical development of its Covid-19 vaccine. | $6.6M |
Tap an investor to see what else they have backed.
Data is community-curated and may be incomplete.